FASLG

What is FASLG protein?

FASLG gene (Fas ligand) is a protein coding gene which situated on the long arm of chromosome 1 at locus 1q24. The primary function of the encoded transmembrane protein is the induction of apoptosis triggered by binding to FAS. The FAS/FASLG signaling pathway is essential for immune system regulation, including activation-induced cell death (AICD) of T cells and cytotoxic T lymphocyte induced cell death. It has also been implicated in the progression of several cancers. Defects in this gene may be related to some cases of systemic lupus erythematosus (SLE). The FASLG protein is consisted of 281 amino acids and FASLG molecular weight is approximately 31.5 kDa.

What is the function of FASLG protein?

FASLG is a protein that plays a critical role in the regulation of the immune system, particularly in the process of apoptosis or programmed cell death. It is expressed on the surface of activated T cells and binds to the Fas receptor on target cells, triggering a cascade of events that lead to cell death. This interaction is essential for maintaining immune homeostasis by eliminating infected or damaged cells and for preventing autoimmunity. Dysregulation of FASLG has been implicated in various diseases, including autoimmune disorders and cancer, and it is a key factor in the pathogenesis of certain lymphoproliferative syndromes.

FASLG related signaling pathway

The FASLG (Fas Ligand)-related signaling pathway is a critical component in the regulation of programmed cell death, or apoptosis. This pathway involves the interaction between FASLG, a cell surface protein, and its receptor, Fas (CD95), which triggers a cascade of intracellular signals leading to apoptosis. The engagement of Fas by FASLG activates the receptor, resulting in the recruitment of adaptor proteins like FADD (Fas-associated via death domain) and procaspase-8. This complex formation leads to the activation of caspase-8, an initiator caspase that cleaves and activates downstream effector caspases such as caspase-3, ultimately resulting in cellular demolition. This pathway plays a crucial role in maintaining immune system homeostasis, eliminating autoreactive lymphocytes, and mediating cytotoxic T-cell-induced target cell death. Dysregulation of this pathway can contribute to various disease states, including autoimmune disorders, cancer, and inflammatory conditions.

FASLG related diseases

FASLG related diseases encompass a range of pathological conditions characterized by dysregulation of the Fas/FasL apoptotic signaling pathway. This pathway is crucial for maintaining immune system homeostasis and eliminating unwanted or damaged cells. When this pathway is disrupted, it can lead to various diseases. For instance, insufficient FasL activity or expression can impair apoptosis, contributing to autoimmune disorders such as systemic lupus erythematosus (SLE) by allowing autoreactive lymphocytes to escape deletion. Conversely, overexpression or hyperactivity of FasL can lead to excessive apoptosis, implicated in conditions like liver disease (e.g., alcoholic hepatitis) due to uncontrolled killing of hepatocytes. Additionally, deregulation of this pathway can facilitate tumor progression and resistance to chemotherapy in cancers by enabling malignant cells to evade immune surveillance and apoptosis. Therefore, the balance and proper functioning of the FASLG-related signaling pathway are essential for preventing these diverse diseases associated with abnormal cell survival or death.

Fig1. Approaches targeting the Fas/FasL signaling for cancer therapy. (María Villa-Morales, 2012)

Bioapplications of FASLG

FASLG primarily functions by binding to the Fas receptor, triggering a caspase cascade that leads to apoptosis in target cells. It is crucially involved in immune regulation, including T-cell homeostasis and cytotoxicity. FasL is highly expressed on activated T cells and natural killer cells, promoting apoptosis of infected or altered cells and maintaining immune response balance. Deregulation of FasL can lead to autoimmune diseases and tumor development.